MarketsHighSingle-sourceAccelerating
7.1
BioXcel Therapeutics files for bankruptcy and enters material definitive agreement
SEC EDGAR 8-K FilingsLO·US·about 7 hours ago
Management has acquired the Linz-based specialty chemical firm Esim following its bankruptcy, securing the site and 145 of the original 300 jobs. The deal preserves a portion of the workforce, though the long-term viability of the restructured entity remains to be proven.